Biodesix Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Biodesix Inc 's ROA in the second quarter of 2026?
Biodesix Inc recorded a cumulative net loss of $-28 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -30.45%.

However, within the Healthcare sector 425 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3739, from total ROA ranking in the first quarter of 2026 at 4456.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	10.23 %	9.74 %	-10.04 %	-14.58 %	-25.13 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-28	-32	-35	-40	-41
Return On Assets (TTM)	-30.45 %	-35.92 %	-40.6 %	-44.27 %	-44.15 %
BDSX's Total Ranking	# 3739	# 4456	# 3957	# 4005	# 4022
Total Assets (TTM) in million	95	95	87	87	86
Seq. Total Assets Change	0.73 %	8.19 %	0.24 %	0.91 %	0.28 %
Seq. Net Income Change	-	-	-	-	-

BDSX's 5 Years Annual ROA >> Back to BDSX Management Effectiveness >> Compare BDSX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 26
Sector	# 426
Overall	# 3611

Return On Assets Statistics
High	Average	Low
201.57 %	-31.83 %	-89.35 %
(Mar 31 2021)		(Dec 31 2022)

News about Biodesix Inc Return on Assets ROA

Biodesix Breaks Ground at CHEST 2024, Yet Faces Market Headwinds

Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study In a bold maneuver that showcases its commitment to advancing lung disease diagnostics, Biodesix, Inc. (Nasdaq: BDSX) is set to make waves at the highly anticipated CHEST Annual Meeting 2024 in Boston, Massachusetts. On Tuesday, October 8, at 10:20 am ET, the leading diagnostic solutions company will present groundbreaking data that examines the experiences of healthcare providers utilizing the Nodify Lung Nodule Risk Assessment. This innovative assessment tool has been pivotal in analyzing over 35,000 patients in a real-world clinical setting.As Biodesix prepares to unveil this substantial body of work, industry observers are keenly focused on what it means for the future of lung cancer detection and patient care. The Nodify platform has garnered attention for its potential to enhance the accuracy of lung nodule assessments, ultimately leading to quicker, more informed treatment decisions. This presentation could solidify Biodesix s position as a key player in the realm of diagnostic solutions.

Financial Statements
Biodesix Inc 's Assets	$ 95 million	BDSX's Balance sheet
Biodesix Inc 's Income	$ -7 million	Quarterly BDSX's Income Statement
BDSX's Income by Division		See BDSX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-10.04 %	-1.87 %	7.7 %	20.91 %	-37.15 %
Total Assets in million	87	97	99	92	76
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-35	-43	-52	-65	-43
Annual Return On Assets	-40.31 %	-44.15 %	-52.62 %	-71.13 %	-56.72 %

BDSX's 5 Years Annual ROA >> Back to BDSX Management Effectiveness >> Compare BDSX ROA to its Competitors

More Return On Assets Ratios
BDSX's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BDSX's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BDSX's Competitors
Subscribers only: Roa for Biodesix Inc 's Suppliers
Subscribers only: Return On Assets for BDSX's Customers

You may also want to know
BDSX's Roi	BDSX's Inventory Turnover Ratio	BDSX's Growth Rates	BDSX's Dividend Comparisons
	BDSX's Profitability Ratios	BDSX's Asset Turnover Ratio	BDSX's Dividend Growth
BDSX's Roe	BDSX's Valuation Ratios	BDSX's Financial Strength Ratios	BDSX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-10T09:11:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.